Meleti M, Cassi D, Vescovi P, Setti G, Pertinhez TA, Pezzi ME. Salivary biomarkers for diagnosis of systemic diseases and malignant tumors. A systematic review. Med Oral Patol Oral Cir Bucal. 2020 Mar 1;25 (2):e299-310.
doi:10.4317/medoral.23355
https://dx.doi.org/doi:10.4317/medoral.23355
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1. Aro K, Wei F, Wong DT, Tu M. Saliva Liquid Biopsy for Point-of-Care Applications. Front Public Health. 2017;5:77. |
PMid:28443278 PMCid:PMC5387045 |
2. Yager P, Domingo GJ, Gerdes J. Point-of-Care Diagnostics for Global Health. Annu Rev Biomed Eng. 2008;10:107-44. |
PMid:18358075 |
3. Kaczor-Urbanowicz KE, MartinCarreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics - Current views and directions. Exp Biol Med. 2017;242:459-72. |
PMid:27903834 PMCid:PMC5367650 |
4. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools |
5. Phillips B et al. Oxford Centre for Evidence-based Medicine-Levels of Evidence. 2009. Retrieved from http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ |
6. Feng S, Huang S, Lin D, Chen G, Xu Y, Li Y, et al. Surface-enhanced Raman spectroscopy of saliva proteins for the noninvasive differentiation of benign and malignant breast tumors. Int J Nanomedicine. 2015;10:537-47. |
PMid:25609959 PMCid:PMC4298339 |
7. Laidi F, Bouziane A, Zaoui F. Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status. Onco Targets Ther. 2014;7:1285-89. |
PMid:25053886 PMCid:PMC4105270 |
8. Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci. 2012;69:3341-50. |
PMid:22689099 PMCid:PMC4121486 |
9. Koizumi T, Shetty V, Yamaguchi M. Salivary cytokine panel indicative of non-small cell lung cancer. J Int Med Res. 2018;46:3570-82. |
PMid:29916282 PMCid:PMC6136026 |
10. Wei F, Lin CC, Joon A et al. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med. 2014;190:1117-26. |
PMid:25317990 PMCid:PMC5447327 |
11. Yang J, Mu X, Wang Y, Zhu D, Zhang J, Liang C, Chen B et al. Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers. Front Oncol. 2018;8:520. |
PMid:30524957 PMCid:PMC6256243 |
12. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, et al. Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer. Gastroenterology. 2010;138:949-57. |
PMid:19931263 PMCid:PMC2831159 |
13. Xie Z, Yin X, Gong B, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res. 2015;8:165-3. |
PMid:25538087 |
14. Holten-Andersen L, Christensen IJ, Jensen SB, Reibel J, Laurberg S, Nauntofte B, et al. Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study. Scand J Gastroenterol. 2012;47:1234-41. |
PMid:22871105 |
15. Shu J, Yu H, Li X, Zhang D, Liu X, Du H. Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer. Oncotarget. 2017;8:35718-27. |
PMid:28415698 PMCid:PMC5482611 |
16. Sun JH, Li XL, Yin J, Li YH, Hou BX, Zhang Z. A screening method for gastric cancer by oral microbiome detection. Oncol Rep. 2018;39:2217-24. |
PMid:29498406 |
17. Li F, Yoshizawa JM, Kim KM, Kanjanapangka J, Grogan TR, Wang X, et al. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer. Clin Chem. 2018;64:1513-21. |
PMid:30097497 |
18. Masters JM, Noyce AJ, Warner TT, Giovannoni G, Proctor GB. Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity. Parkinsonism relat disord. 2015;21:1251-5. |
PMid:26231472 |
19. Ahmadi-Motamayel F, Goodarzi MT, Tarazi S, Vahabian M. Evaluation of salivary acetylcholinesterase and pseudocholinesterase in patients with Alzheimer's disease: A case-control study. Spec Care Dentist. 2019;39:39-44. |
PMid:30536408 |
20. Mirzaii-Dizgah I, Riahi E. Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction. Oral Dis. 2013;19:180-4. |
PMid:22834943 |
21. Mirzaii-Dizgah I, Jafari-Sabet M. Unstimulated whole saliva creatine phosphokinase in acute myocardial infarction. Oral Dis. 2011;17:597-600. |
PMid:21635668 |
22. Mirzaii-Dizgah I, Hejazi SF, Riahi E, Salehi MM. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction. Clin Oral Investig. 2012;16:775-9. |
PMid:21681388 |
23. Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, et al. Use of Saliva-Based Nano-Biochip Tests for Acute Myocardial Infarction at the Point of Care: A Feasibility Study. Clin chem. 2009;55:1530-8. |
PMid:19556448 |
24. Mirzaii-Dizgah I, Riahi E. Serum and Saliva Levels of Cathepsin L in Patients with Acute Coronary Syndrome. J Contemp Dent Pract. 2011;12:114-9. |
PMid:22186754 |
25. Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World journal of gastroenterology. 2009;15:865-70. |
PMid:19230049 PMCid:PMC2653388 |
26. Giusti L, Baldini C, Ciregia F, Giannaccini G, Giacomelli C, De Feo F, et al. Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? Proteomics Clinical Appl. 2010;4:315-24. |
PMid:21137052 |
27. Streckfus C, Bigler L, Tucci M, Thigpen JT. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 2000;18:101-9. |
PMid:10705871 |
28. Streckfus C, Bigler L. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv Dent Res. 2005;18:17-24. |
PMid:15998939 |
29. Turan T, Demir S, Aybek H, Atahan O, Tuncay OL, Aybek Z, et al. Free and Total Prostate-Specific Antigen Levels in Saliva and the Comparison with Serum Levels in Men. Eur Urol. 2000;38:550-4. |
PMid:11096235 |
30. Streckfus CF, Bigler LR, Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: A feasibility study. J Oral Pathol Med. 2006;35:292-300. |
PMid:16630293 |
31. Brooks MN, Wang J, Li Y, Zhang R, Elashoff D, Wong DT. Salivary protein factors are elevated in breast cancer patients. Mol Med Rep. 2008;1:375-8. |
PMid:19844594 PMCid:PMC2763326 |
32. Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal. 2009;14:521-4. |
PMid:19680209 |
33. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6:78-95. |
PMid:20300169 PMCid:PMC2818837 |
34. Rao PV, Reddy AP, Lu X, Dasari S, Krishnaprasad A, Biggs E et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res. 2009;8:239-45. |
PMid:19118452 |
35. Pandeshwar P, Das R. Role of oral fluids in DNA investigations. J Forensic Leg Med. 2014;22:45-50. |
PMid:24485421 |
36. Valentini A, Miquel C, Nawaz MA, Bellemain E, Coissac E, Pompanon F et al. New perspectives in diet analysis based on DNA barcoding and parallel pyrosequencing: the trnL approach. Mol Ecol Resour. 2009;9:51-60. |
PMid:21564566 |
37. Vivacqua G, Suppa A, Mancinelli R, Belvisi D, Fabbrini A, Costanzo M, et al. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy. Parkinsonism Relat Disord. 2019. |
PMid:30796010 |
38. Marksteiner J, Oberacher H, Humpel C. Acyl-Alkyl Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer's Disease as Identified by Targeted Metabolomics. J Alzheimers Dis. 2019;68:583-89. |
PMid:30814361 |
39. Julious SA. Sample sizes for clinical trials with normal data. Stat Med. 2004;23:1921-86. |
PMid:15195324 |
40. Pu D, Liang H, Wei F et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study. Thorac Cancer. 2016;7:428-36. |
PMid:27385985 PMCid:PMC4930962 |
41. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut Statist. 2005;4:287-91. |
42. Faggion CM Jr. Evaluating the Risk of Bias of a Study. J Evid Based Dent Pract. 2015;15:164-70. |
PMid:26698002 |
43. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359-86. |
PMid:25220842 |
44. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87-108. |
PMid:25651787 |
45. Layke JC, Lopez PP. Gastric Cancer: Diagnosis and Treatment Options. Am Fam Physician. 2004;69:1133-40. |
PMid:15023013 |
46. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24:4846-61. |
PMid:30487695 PMCid:PMC6250924 |
47. Chen Y, Cheng S, Zhang A, Song J, Chang J, Wang K, et al. Salivary Analysis Based on Surface Enhanced Raman Scattering Sensors Distinguishes Early and Advanced Gastric Cancer Patients from Healthy Persons. J Biomed Nanotechnol. 2018;14:1773-84. |
PMid:30041723 |
48. Shu J, Yu H, Du H, Zhang J, Zhang K, Li X. Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer. Cancer Biomark. 2018;22:1-13. |
PMid:29865036 |
49. Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, et al. Differential Proteomic Analysis of Human Saliva using Tandem Mass Tags Quantification for Gastric Cancer Detection. Sci Rep. 2016;6:22165. |
PMid:26911362 PMCid:PMC4766442 |
50. Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009;22:241-8. |
PMid:19824562 |
51. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, et al. DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010;133:713-26. |
PMid:20157014 PMCid:PMC2842513 |
52. Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376:1094-108. |
PMid:20870100 |
53. Javaid MA, Ahmed AS, Durand R, Tran SD. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016;6:67-76. |
PMid:26937373 PMCid:PMC4756071 |
54. Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2012;11:M111.012112. |
PMid:22096114 PMCid:PMC3277759 |
55. Lee YH, Kim JH, Zhou H, Kim BW, Wong DT. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med. 2012;90:427-34. |
PMid:22095100 |
56. Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One. 2010;5:e15573. |
PMid:21217834 PMCid:PMC3013113 |
57. Li X, Yang T, Lin J. Spectral analysis of human saliva for detection of lung cancer using surface-enhanced Raman spectroscopy. J Biomed Opt. 2012;17:037003. |
PMid:22502575 |
58. De Abreu Pereira D, Areias VR, Franco MF, Benitez MC, do Nascimento CM, de Azevedo CM, et al. Measurement of HER2 in saliva of women in risk of breast cancer. Pathol Oncol Res. 2013;19:509-13. |
PMid:23479082 |
59. Chen D, Song N, Ni R, Zhao J, Hu J, Lu Q, et al. Saliva as a sampling source for the detection of leukemic fusion transcripts. J Transl Med. 2014;12:321. |
PMid:25407125 PMCid:PMC4243783 |
60. Cheng F, Wang Z, Huang Y, Duan Y, Wang X. Investigation of salivary free amino acid profile for early diagnosis of breast cancer with ultra performance liquid chromatography-mass spectrometry. Clin Chim Acta. 2015;447:23-31. |
PMid:25987308 |
61. Humeau M, Vignolle-Vidoni A, Sicard F, Martins F, Bournet B, Buscail L. Salivary MicroRNA in Pancreatic Cancer Patients. PLoS One. 2015;10:e0130996. |
PMid:26121640 PMCid:PMC4486170 |
62. Yan X, Yang M, Liu J, Gao R, Hu J, Li J, et al. Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res. 2015;5:3111-22. |
PMid:26693063 |
63. Delmonico L, Moreira Ados S, Franco MF, Esteves EB, Scherrer L, Gallo CV, et al. CDKN2A (p14(ARF)/p16(INK4a)) and ATM promoter methylation in patients with impalpable breast lesions. Hum Pathol. 2015;46:1540-7. |
PMid:26255234 |
64. Takayama T, Tsutsui H, Shimizu I, Toyama T, Yoshimoto N, Endo Y, et al. Diagnostic approach to breast cancer patients based on target metabolomics in saliva by liquid chromatography with tandem mass spectrometry. Clin Chim Acta. 2016;452:18-26. |
PMid:26523874 |
65. Torres PJ, Fletcher EM, Gibbons SM, Bouvet M, Doran KS, Kelley ST. Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ. 2015;3:e1373. |
PMid:26587342 PMCid:PMC4647550 |
66. Wood N, Streckfus CF. The Expression of Lung Resistance Protein in Saliva: A Novel Prognostic Indicator Protein for Carcinoma of the Breast. Cancer Invest. 2015;33:510-5. |
PMid:26506284 |
67. Tsutsui H, Mochizuki T, Inoue K, Toyama T, Yoshimoto N, Endo Y, et al. High-throughput LC-MS/MS based simultaneous determination of polyamines including N-acetylated forms in human saliva and the diagnostic approach to breast cancer patients. Anal Chem. 2013;85:11835-42. |
PMid:24274257 |
68. Xie Z, Chen X, Li J, Guo Y, Li H, Pan X, et al. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer. Oncotarget. 2016;7:25408-19. |
PMid:27028998 PMCid:PMC5041913 |
69. Zhong L, Cheng F, Lu X, Duan Y, Wang X. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Talanta. 2016;158:351-60. |
PMid:27343615 |
70. Machida T, Tomofuji T, Maruyama T, Yoneda T, Ekuni D, Azuma T et al. miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncol Rep. 2016;36:2375-81. |
PMid:27573701 |
71. Liu HJ, Guo YY, Li DJ. Predicting novel salivary biomarkers for the detection of pancreatic cancer using biological feature-based classification. Pathol Res Pract. 2017;213:394-99. |
PMid:28283209 |
72. Bel'skaya L. The activity of metabolic enzymes in the saliva of lung cancer patients. Natl J Physiol Pharm Pharmacol. 2017;7:646-53. |
73. Sun Y, Liu S, Qiao Z, Shang Z, Xia Z, Niu X, et al. Systematic comparison of exosomal proteomes from human saliva and serum for the detection of lung cancer. Anal Chim Acta. 2017;982:84-95. |
PMid:28734369 |
74. Laidi F, Bouziane A, Errachid A, Zaoui F. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening. Asian Pac J Cancer Prev. 2016;17:335-9. |
PMid:26838233 |
75. Hernández-Arteaga A, de Jesús Zermeño Nava J, Kolosovas-Machuca ES, Velázquez-Salazar J, et al. Diagnosis of breast cancer by analysis of sialic acid concentrations in human saliva by surface-enhanced Raman spectroscopy of silver nanoparticles. Nano Res. 2017;10:3662-70. |
76. Cavaco C, Pereira JAM, Taunk K, Taware R, Rapole S, Nagarajaram H, et al. Screening of salivary volatiles for putative breast cancer discrimination: an exploratory study involving geographically distant populations. Anal Bioanal Chem. 2018;410:4459-68. |
PMid:29732495 |
77. Zermeño-Nava JJ, Martínez-Martínez MU, Rámirez-de-Ávila AL, Hernández-Arteaga AC, García-Valdivieso MG, Hernández-Cedillo A, et al. Determination of sialic acid in saliva by means of surface-enhanced Raman spectroscopy as a marker in adnexal mass patients: ovarian cancer vs benign cases. J Ovarian Res. 2018;11:61. |
PMid:30041680 PMCid:PMC6058371 |
78. Tajmul M, Parween F, Singh L, Mathur SR, Sharma JB, Kumar S, et al. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer. Int J Biol Macromol. 2018;108:503-14. |
PMid:29222021 |
79. Zhang J, Zhong Y, Zhang P, Du H, Shu J, Liu X, et al. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Glycobiology. 2019;29:242-59. |
PMid:30535277 |
80. Xie Z, Zhou F, Yang Y, Li L, Lei Y, Lin X, et al. Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma. EBioMedicine. 2018;33:57-67. |
PMid:30045829 PMCid:PMC6085584 |
81. Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, Pan C, et al. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain. 2011;134:e178. |
PMid:21349902 PMCid:PMC3122368 |
82. Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, et al. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013;34:2865-72. |
PMid:23857558 |
83. Al-Nimer MS, Mshatat SF, Abdulla HI. Saliva α-Synuclein and A High Extinction Coefficient Protein: A Novel Approach in Assessment Biomarkers of Parkinson's Disease. N Am J Med Sci. 2014;6:633-7. |
PMid:25599051 PMCid:PMC4290052 |
84. Liang Q, Zhang T and Jiang Y, et al. Metabolomics-Based Screening of Salivary Biomarkers for Early Diagnosis of Alzheimer's Disease. RSC Adv. 2015;5:96074-9. |
85. Liang Q, Liu H, Li X, et al. High-throughput metabolomics analysis discovers salivary biomarkers for predicting mild cognitive impairment and Alzheimer's disease. RSC Adv. 2016;6:75499-504. |
86. Yilmaz A, Geddes T, Han B, Bahado-Singh RO, Wilson GD, Imam K, et al. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics. Alzheimers Dis. 2017;58:355-9. |
PMid:28453477 |
87. Ashton NJ, Ide M, Schöll M, Blennow K, Lovestone S, Hye A, et al. No association of salivary total tau concentration with Alzheimer's disease. Neurobiol Aging. 2018;70:125-7. |
PMid:30007161 |
88. Cao Z, Wu Y, Liu G, Jiang Y, Wang X, Wang Z, et al. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease. Neurosci Lett. 2019;696:114-20. |
PMid:30579996 |
89. Song W, Kothari V, Velly AM, Cressatti M, Liberman A, Gornitsky M, et al. Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinson's disease. Mov Disord. 2018;33:583-91. |
PMid:29488275 |
90. Manconi B, Liori B, Cabras T, Vincenzoni F, Iavarone F, Lorefice L, et al. Top-down proteomic profiling of human saliva in multiple sclerosis patients. J Proteomics. 2018;187:212-22. |
PMid:30086402 |
91. Buduneli E, Mäntylä P, Emingil G, Tervahartiala T, Pussinen P, Barış N, et al. Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. J Periodontol. 2011;82:716-25. |
PMid:21091346 |
92. Silva DG, Stevens RH, Macedo JM, Hirata R, Pinto AC, Alves LM, et al. Higher levels of salivary MUC5B and MUC7 in individuals with gastric diseases who harbor Helicobacter pylori. Arch Oral Biol. 2009;54:86-90. |
PMid:18817906 |
93. Mirzaii-Dizgah I, Riahi E. Salivary troponin I as an indicator of myocardial infarction. Indian J Med Res. 2013;138:861-5. |
PMid:24521627 |
94. Adornetto G, Fabiani L, Volpe G, De Stefano A, Martini S, Nenna R, et al. An electrochemical immunoassay for the screening of celiac disease in saliva samples. Anal Bioanal Chem. 2015;407:7189-96. |
PMid:26168969 |
95. Gang Cao, Maowen Chen, Yuanxiang Chen, Zufang Huang, Jinyong Lin, Jia Lin, et al. A potential method for non-invasive acute myocardial infarction detection based on saliva Raman spectroscopy and multivariate analysis. Laser Phys. 2015;12:125702. |
96. Giusti L, Sernissi F, Donadio E, et al. Salivary psoriasin (S100A7) correlates with diffusion capacity of carbon monoxide in a large cohort of systemic sclerosis patients. J Transl Med. 2016;14:262. |
PMid:27608975 PMCid:PMC5015208 |
97. Lu C, Hou X, Li M., Wang L, Zeng P, Jia H, et al Detection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitis. Sci Rep. 2017;7:796. |
PMid:28400582 PMCid:PMC5429755 |
98. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. |
PMid:19621072 PMCid:PMC2707599 |